Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shaklee in China

This article was originally published in The Tan Sheet

Executive Summary

The manufacturer and multi-level marketer of nutrition and personal care products opens its doors in Beijing. Shaklee China is built upon two manufacturing facilities, a service center, 18 pick-up centers and a Beijing office, the company says Jan. 15. Shaklee has existing international operations in Canada, Japan, Malaysia, Mexico and Taiwan, and now feels "welcomed by health-conscious Chinese consumers," says Joseph Lee, general manager for Shaklee China. The Pleasanton, Calif.-based firm received a direct-selling license from China's Ministry of Commerce nearly two years ago and has since invested millions in its operations there (1"The Tan Sheet" April 2, 2007, In Brief)

The manufacturer and multi-level marketer of nutrition and personal care products opens its doors in Beijing. Shaklee China is built upon two manufacturing facilities, a service center, 18 pick-up centers and a Beijing office, the company says Jan. 15. Shaklee has existing international operations in Canada, Japan, Malaysia, Mexico and Taiwan, and now feels "welcomed by health-conscious Chinese consumers," says Joseph Lee, general manager for Shaklee China. The Pleasanton, Calif.-based firm received a direct-selling license from China's Ministry of Commerce nearly two years ago and has since invested millions in its operations there (1 'The Tan Sheet' April 2, 2007, In Brief).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel